| CHCLX | PMBJX | CHCLX / PMBJX | |
| Total Expense Ratio | 0.93 | 0.78 | 119% |
| Annual Report Gross Expense Ratio | 0.94 | 0.78 | 121% |
| Fund Existence | 87 years | 25 years | - |
| Gain YTD | -0.765 | -0.564 | 136% |
| Front Load | 4% | N/A | - |
| Min. Initial Investment | 2500 | 1000 | 250% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.45B | 30.9B | 8% |
| Annual Yield % from dividends | 0.00 | 0.06 | - |
| Returns for 1 year | -2.75 | -6.53 | 42% |
| Returns for 3 years | 33.37 | 32.39 | 103% |
| Returns for 5 years | -21.26 | 24.63 | -86% |
| Returns for 10 years | 27.82 | 89.12 | 31% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| GDMN | 80.11 | 1.33 | +1.69% |
| WisdomTree Efcnt Gld Pls Gld Ms Stgy ETF | |||
| IBB | 166.47 | 1.21 | +0.73% |
| iShares Biotechnology ETF | |||
| ILTB | 50.22 | 0.03 | +0.06% |
| iShares Core 10+ Year USD Bond ETF | |||
| SIXP | 30.76 | -0.12 | -0.39% |
| AllianzIM US Lrg Cp 6M Bfr10 Mar/Sep ETF | |||
| EFAA | 52.28 | -0.71 | -1.34% |
| Invesco MSCI EAFE Income Advantage ETF | |||